fin
DESCRIPTION
ESC Guias Revascularización miocárdica ESC Guias Revascularización miocárdica Contents: ESC Guias Revascularización miocárdica ESC Guias Revascularización miocárdica Optimal Medical Therapy •Antiischemic drugs •Antithrombotic treatment •Secondary prevention •Rehabilitation Patient Risk www.umassmed.edu/ outcomes/grace Scores to calculate ESC Guias Revascularización miocárdica Scores to calculate Risk of PCI & CABGTRANSCRIPT
ESC Guias Revascularización miocárdica
ESC Guias Revascularización miocárdicaContents:
• Strategies of Diagnosis & severity of ischemia
• Optimal medical therapy
• Risk stratification. Clinical risk scores
• Procedural risk scores
• Heart Team: Multidisciplinary opinion
• Patient informed decision
• Specific recommendations
• Special Conditions
ESC Guias Revascularización miocárdica
ESC Guias Revascularización miocárdica
Optimal Medical Therapy• Antiischemic drugs• Antithrombotic treatment• Secondary prevention • Rehabilitation
ESC Guias Revascularización miocárdica
www.umassmed.edu/outcomes/grace
Scores to calculate Patient Risk
ESC Guias Revascularización miocárdicaScores to calculate Risk of PCI & CABG
ESC Guias Revascularización miocárdica
Patient information Patient active role in decissions•Objective, •Unbiased, •Patient-oriented, •Evidence-based, •Up-to-date, reliable, •Understandable, •Accessible, •Relevant,•Consistent with legal requirements
ESC Guias Revascularización miocárdicaPatient information (Apendix in guidelines)
ESC Guias Revascularización miocárdicaPatient information (Apendix in guidelines)
ESC Guias Revascularización miocárdicaPatient information (Apendix in guidelines)
ESC Guias Revascularización miocárdicaPatient information (Apendix in guidelines)
ESC Guias Revascularización miocárdicaMultidisciplinary Decision Pathways, Patient Info/consent & Timing of Intervention
The Heart Team
ESC Guias Revascularización miocárdicaMultidisciplinary Decision Pathways, Patient Info/consent & Timing of Intervention
ESC Guias Revascularización miocárdica
RevascularizationInSTE-ACS
ESC Guias Revascularización miocárdica
RevascularizationinNon STE-ACS
Risk Stratification in NSTE-ACS: Risk Stratification in NSTE-ACS:
0
500
1,000
1,500
2,000
2,500
3,000
3,500
GRACE risk score intervals
Patie
nts
(n)
0
5
10
15
20
25
30
35
40
Inho
spita
l mor
talit
y (%
)Troponin −Troponin +Mortality
0
500
1,000
1,500
2,000
2,500
3,000
3,500
GRACE risk score intervals
Patie
nts
(n)
0
5
10
15
20
25
30
35
40
Inho
spita
l mor
talit
y (%
)Troponin −Troponin +Mortality
<51
56 66 76 85 95 105 115 125 135 145 155 165 175 185 195 205 214 225 >226
N = 27,406 non-STE ACS patients
High < 140Low < 108
ESC Guias Revascularización miocárdica
PCI vs GABGStable patients
ESC Guias Revascularización miocárdica
RevascularizationinStable patients
Indications for Revascularisation in Stable Angina or Silent Ischaemia
* with documented ischaemia or FFR <0.80 for
angiographic diameter stenoses 50-90%
ESC Guias Revascularización miocárdica
Subset of CAD by anatomy Favours CABG Favours PCI
1VD or 2VD – non proximal LAD IIa C I C 1VD or 2VD – proximal LAD I A IIa B 3VD simple lesions, full functional revascularisation achievable with PCI,SYNTAX SCORE <22
I A IIa B
3VD complex lesions, incomplete revascularisation achievable with PCI,SYNTAX SCORE > 22
I A III A
Left Main (Isolated or 1VD, ostium/shaft) I A IIa B Left Main (Isolated or 1VD, distal bifurcation) I A IIb B Left Main + 2/3VD SYNTAX SCORE <33 I A IIb B Left Main + 2/3VD SYNTAX SCORE>33 I A III B
Indications for CABG vs PCI in candidates for revasc. in stable angina or silent ischaemia with lesions suitable for both procedures & low surgical mortality
ESC Guias Revascularización miocárdicaEuropean Society of Cardiology: 53 countries